Equities

4Dmedical Ltd

4Dmedical Ltd

Actions
  • Price (USD)0.34
  • Today's Change0.00 / 0.00%
  • Shares traded1.40k
  • 1 Year change-27.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024 13:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments317051
Total Receivables, Net5.896.966.37
Total Inventory0.990.670.00
Prepaid expenses1.561.341.37
Other current assets, total------
Total current assets397959
Property, plant & equipment, net8.759.2610
Goodwill, net43----
Intangibles, net295.085.06
Long term investments------
Note receivable - long term0.040.040.04
Other long term assets------
Total assets1209374
LIABILITIES
Accounts payable2.102.861.81
Accrued expenses1.771.301.03
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.940.931.10
Other current liabilities, total17125.62
Total current liabilities22179.56
Total long term debt4.184.215.14
Total debt5.125.146.24
Deferred income tax7.07----
Minority interest------
Other liabilities, total160.190.10
Total liabilities492115
SHAREHOLDERS EQUITY
Common stock218184142
Additional paid-in capital------
Retained earnings (accumulated deficit)(147)(113)(82)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.36)(0.15)0.01
Total equity717160
Total liabilities & shareholders' equity1209374
Total common shares outstanding410345295
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.